TT levels are subjected to variations related to the circulating levels of Sex-Hormone Binding Globulin (SHBG), which is produced in the liver and can be mildly reduced under states of obesity, insulin resistance, and NAFLD. The gene discussed is SHBG; the disease is metabolic dysfunction-associated steatotic liver disease.